Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
YS Biopharma Co Ltd - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
YS
Nasdaq
2836
https://www.ysbiopharm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for YS Biopharma Co Ltd
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- Apr 29th, 2024 12:00 pm
YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript
- Apr 22nd, 2024 1:10 pm
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
- Apr 19th, 2024 11:00 am
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
- Apr 18th, 2024 12:00 pm
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
- Apr 16th, 2024 12:00 pm
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
- Apr 9th, 2024 12:00 pm
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
- Apr 3rd, 2024 12:00 pm
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
- Mar 5th, 2024 1:00 pm
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
- Feb 22nd, 2024 10:00 pm
/C O R R E C T I O N -- YS Biopharma Co., Ltd./
- Feb 18th, 2024 9:30 am
YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance
- Feb 14th, 2024 1:00 pm
YS Biopharma Announces Appointment of New Directors
- Feb 14th, 2024 12:50 pm
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
- Feb 12th, 2024 1:50 pm
YS Biopharma Announces US$40 Million Private Placement Financing
- Feb 9th, 2024 11:30 am
Shareholders of YS Biopharma Announce an Extraordinary General Meeting
- Feb 8th, 2024 11:10 pm
Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)
- Jan 24th, 2024 9:00 pm
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
- Jan 22nd, 2024 10:00 pm
YS Biopharma Announces Changes to its Board Committees
- Jan 8th, 2024 1:00 pm
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting
- Dec 20th, 2023 9:30 pm
When Can We Expect A Profit From YS Biopharma Co., Ltd. (NASDAQ:YS)?
- Nov 15th, 2023 10:51 am
Scroll